Company Updates
Alcidion to Meet with NSW Health Minister
New South wales Governemnt Policy requires certain details of meetings held with the Minister to be publicly disclosed ona quarterly basis.
Alcidion Group Quarterly Report: Successful Reverse Takeover of Naracoota Resources, Commercialiation Strategy Commenced
Alcidion’s first quarter following the successful reverse takeover of Naracoota Resources Limited marked the commencement of the Company’s commercialisation strategy of its Miya platform.
Leaf Resources Quarter Update June 2016: Expecting to Receive $510,000 from R & D Tax Rebate
Attached to this update are the current quarterly cash report (Appendix 4C) for the quarter ended 30th June 2016.
Alcidion FY16 Update: Public Listing, $2.35m MoU with Western Health, $2.20m to Research & Development
Alcidion FY16 Update: Public Listing, $2.35m MoU with Western Health, $2.20m to Research & Development
Dimerix FY16 Update: Significant Progress on its DMX-200 Program, FDA Confirmation, Trial Recruiting Well
Dimerix has made significant progress on its DMX-200 program for chronic kidney disease. Dimerix met with the US Food and Drug Administration (FDA) discussing DMX-200 development for Focal Segmental Glomerularsclerosis (FSGS). Dimerix confirmed the DMX-200 regulatory path as an adjunct therapy, not a combination therapy, reducing complexity and costs of trials. Proteinuria is a risk […]
ThinCats Australia Joins Forces with Leading Property Crowdfunder DomaCom
Investment platform operator DomaCom and SME peer-to-peer lender ThinCats will collaborate to provide greater scope for exposure to property and loan opportunities. In its announcement on Friday, DomaCom – soon to be listed as a crowdfunding service – said Australia’s peer-to-peer business lending sector had benefited from the tightening of bank lending to small to […]
Medikane FY16 Update: $500,000 Raised, Share Price Increased 22%, Appointing Distributors in India, Thailand, Sri Lanka, and Oman
MediKane raised $500,000 recently which increased the share price by 22%. Ex Hardie Exec VP Peter Baker joined the Board and Michael Goldman ex Diabetes Australia joined as Senior VP USA posted in New York. The business is appointing distributors in India, Thailand, Sri Lanka, and Oman. MediKane’s diabetes treatment NutriKane D appeared in the health […]
SUDA Quarter Update June 2016: Cash Position at $2.4 million
29th July 201 SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today released its Appendix 4C for the consolidated Group for the fourth quarter of FY2016. Receipts from customers for the period were $1.5 million, an increase of 12% from the fourth quarter of FY2015. The net operating cash loss for the fourth […]
Alcidion (ASX:ALC) Sign $2.35m MoU with Western Health
Western Health has signed a $2.35m Memorandum of Understanding with Alcidion Group Limited (ASX:ALC) to utilise the company’s technology across its three facilities.
Backed By Leading Investment Groups and Family Offices
